Varian's Q1 Revenues Slip in Advance of Agilent Merger Completion | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Varian has reported a 3 percent decline in its first quarter results, as the firm nears completion of its merger with Agilent Technologies.

The Palo Alto, Calif.-based maker of scientific instruments and other technologies today filed its first quarter financial report with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.